PRAGUE, Czech Republic, April 24, 2018 -- This week at the industry’s premier flow cytometry conference, CYTO 2018, Cytek Biosciences Inc. will be on the show floor highlighting its CytekTM Aurora flow cytometry system with enhanced features. This unique platform has been embraced by researchers around the world since making its debut at CYTO 2017, and the deployments so far have been validating the application flexibility of the Cytek Aurora. From extra-cellular vesicles to highly multiparametric applications beyond what were initially envisioned and more, the breadth of applications being performed on the Cytek Aurora continues to grow.
“At this time last year, we introduced the scientific community to an all-new full spectrum flow cytometer that enables new discoveries and deeper biological insights at an affordable cost,” noted Dr. Wenbin Jiang, CEO of Cytek Biosciences. “Now, Cytek Aurora has been sold into four continents and is at work all over the globe. CYTO 2018 is the perfect place for us to showcase how we have expanded Cytek Aurora’s features and application abilities over the past year and set the stage for future innovations to come.”
Cytek Aurora offers capabilities that go beyond flow cytometry systems that come with a much higher price tag. With a simplified workflow, greater flexibility, and a lower cost of ownership, the Cytek Aurora is the embodiment of Cytek’s mission to make high end, high quality flow cytometry accessible to a larger number of researchers.
Cytek Aurora will be demonstrated at CYTO 2018 in Prague, Czech Republic, from April 28 – May 2 at booth #33. CYTO attendees are also encouraged to learn more about the Cytek Aurora through the following CYTO events and displays:
-
- Wednesday, May 2 – Commercial Tutorial: ‘Expanding Application Capabilities Using Full Spectrum Cytometry’
- Poster: ‘Minimizing the Effects of Spectral Overlap by Unmixing Versus Compensation,’ Program Number: 294. Poster Board Number: B289.
Please visit www.cytekbio.com for more information.
About Cytek Biosciences
Cytek Biosciences Inc. is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. To learn more, visit www.cytekbio.com and follow them on LinkedIn.
Media Contact:
Justine Houston-Brown
Lages & Associates
(949) 453-8080
[email protected]
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/0c0b45d4-94bf-44ef-bcd8-8c3cf3b572ad


Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
World game at war: why some European nations have threatened a World Cup boycott
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Japan Earthquake Disrupts Auto and Chip Supply Chains
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 



